1,953 results on '"Preston, Mark A."'
Search Results
2. Oncologic Outcomes of Sequential Intravesical Gemcitabine and Docetaxel Compared with Bacillus Calmette-Guérin in Patients with Bacillus Calmette-Guérin–Unresponsive Non–Muscle Invasive Bladder Cancer
3. A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with 18F-DCFPyL in Prostate Cancer Patients (OSPREY).
4. Diagnostic Performance and Safety of Positron Emission Tomography with 18F-rhPSMA-7.3 in Patients with Newly Diagnosed Unfavourable Intermediate- to Very-high-risk Prostate Cancer: Results from a Phase 3, Prospective, Multicentre Study (LIGHTHOUSE)
5. Association Between Antibiotic Prophylaxis Before Cystectomy or Stent Removal and Infection Complications: A Systematic Review
6. Risk of cardiovascular events following intermittent and continuous androgen deprivation therapy in patients with nonmetastatic prostate cancer
7. America in the World: A History in Documents since 1898, Revised and Updated
8. Incidence of Germline Variants in Familial Bladder Cancer and Among Patients With Cancer Predisposition Syndromes
9. Genomic Features of Muscle-invasive Bladder Cancer Arising After Prostate Radiotherapy
10. Correlation of circulating tumor DNA (ctDNA) dynamics with clinical response in patients with muscle-invasive bladder cancer (MIBC) undergoing trimodality therapy (TMT).
11. MP43-20 DEVELOPMENT AND EARLY TESTING OF A PROTOTYPE FOR NANOSENSOR-ENABLED CHEMICAL CYSTOSCOPY
12. MP08-15 SMOKING STATUS IS ASSOCIATED WITH POOR MENTAL HEALTH IN BLADDER CANCER PATIENTS AND SURVIVORS
13. PD50-10 FREE PSA AND RISK OF GLEASON GRADE GROUP ≥2 AND FATAL PROSTATE CANCER IN BLACK MEN: IMPLICATIONS FOR RISK-STRATIFIED SCREENING
14. Clinical characterization of radiation-associated muscle-invasive bladder cancer
15. ETS factors are required but not sufficient for specific patterns of enhancer activity in different endothelial subtypes
16. Anticoagulation prophylaxis patterns following retroperitoneal lymph node dissection for testis cancer
17. Sequential intravesical gemcitabine/docetaxel provides a durable remission in recurrent high-risk NMIBC following BCG therapy
18. Alvimopan Is Associated With a Reduction in Length of Stay and Hospital Costs for Patients Undergoing Radical Cystectomy
19. Impact of Family History and Germline Genetic Risk Single Nucleotide Polymorphisms on Long-Term Outcomes of Favorable-Risk Prostate Cancer
20. A Provider-Facing Decision Support Tool for Prostate Cancer Screening in Primary Care: A Pilot Study
21. THE RELATIONSHIP BETWEEN SMOKING STATUS AND POOR MENTAL HEALTH IN BLADDER CANCER PATIENTS AND SURVIVORS
22. Provider Perceptions of an Electronic Health Record Prostate Cancer Screening Tool
23. ONCOLOGIC OUTCOMES OF GEMCITABINE-DOCETAXEL COMBINATION INTRAVESICAL BLADDER SPARING THERAPY COMPARED TO UPFRONT RADICAL CYSTECTOMY IN BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER
24. NATURAL HISTORY OF BLADDER-SPARING THERAPY IN PATIENTS WITH BCG-UNRESPONSIVE DISEASE; RESULTS FROM A LARGE MULTI-CENTER COHORT
25. Contemporary Perioperative Outcomes of Open Retroperitoneal Lymph Node Dissection for Testicular Cancer
26. Institutional trends and safety profile of same-day discharge for robot-assisted laparoscopic radical prostatectomy: A retrospective analysis
27. The association of diabetes with risk of prostate cancer defined by clinical and molecular features
28. A model combining clinical and genomic factors to predict response to PD-1/PD-L1 blockade in advanced urothelial carcinoma
29. Gleason 6 Prostate Cancer: Translating Biology into Population Health
30. An inter-laboratory study to investigate the impact of the bioinformatics component on microbiome analysis using mock communities
31. Multilevel Analysis of Readmissions After Radical Cystectomy for Bladder Cancer in the USA: Does the Hospital Make a Difference?
32. Contemporary Survival Rates for Muscle-Invasive Bladder Cancer Treated With Definitive or Non-Definitive Therapy
33. Micropapillary Urothelial Carcinoma of the Bladder: A Systematic Review and Meta-analysis of Disease Characteristics and Treatment Outcomes
34. Aspirin Use and Lethal Prostate Cancer in the Health Professionals Follow-up Study
35. Baseline Prostate-specific Antigen Level in Midlife and Aggressive Prostate Cancer in Black Men
36. Development of a candidate reference material for adventitious virus detection in vaccine and biologicals manufacturing by deep sequencing
37. Goal-Related Feedback Seeking, Receiving Goal-Related Feedback, and Internal Work Motivation: A Two-Sample Mediation Study Using Human Service Case Managers.
38. Postradical prostatectomy prostate‐specific antigen outcomes after 6 versus 18 months of perioperative androgen‐deprivation therapy in men with localized, unfavorable intermediate‐risk or high‐risk prostate cancer: Results of part 2 of a randomized phase 2 trial
39. Prostate Safety Events During Testosterone Replacement Therapy in Men With Hypogonadism
40. Frequent Undetected Ward-Based Methicillin-Resistant Staphylococcus aureus Transmission Linked to Patient Sharing Between Hospitals
41. Preoperative anemia is associated with increased radical cystectomy complications
42. Effectiveness of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer in the Current Real World Setting in the USA
43. Variations in the Costs of Radical Cystectomy for Bladder Cancer in the USA
44. Effect of Nonurothelial Histologic Variants on the Outcomes of Radical Cystectomy for Nonmetastatic Muscle-invasive Urinary Bladder Cancer
45. Contemporary Treatment Patterns and Outcomes for Clinical Stage IS Testicular Cancer
46. Exploiting differential protein stability of a toxin/antitoxin pair for the selective killing of cervical cancer cells
47. Sex specific associations in genome wide association analysis of renal cell carcinoma
48. Evaluating the cost of surveillance for non-muscle-invasive bladder cancer: an analysis based on risk categories
49. Assessment of the Ecological Association between Tobacco Smoking Exposure and Bladder Cancer Incidence over the Past Half-Century in the United States
50. Exploring Patterns of Mitomycin C Use in Community Practice Urology
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.